Related Experiment Video
Updated: Jun 8, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
A de novo mutation in NKX2.5 associated with atrial septal defects, ventricular noncompaction, syncope and sudden
Ping Ouyang1, Elizabeth Saarel, Ying Bai
1Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, and Center for Human Genome Research, Cardio-X Institute, Huazhong University of Science and Technology, Wuhan, PR China.
Insights
A novel NKX2.5 gene mutation (c.512insGC) causes congenital heart defects, including atrial septal defects and ventricular noncompaction, leading to severe symptoms like syncope and sudden death in a family.
Area of Science:
- Genetics
- Molecular Biology
- Cardiology
Background:
- Transcription factor NKX2.5 mutations are a known cause of congenital heart disease (CHD).
- A family presented with a severe CHD phenotype including atrial septal defects (ASDs), atrioventricular block, ventricular noncompaction, syncope, and sudden death.
Purpose of the Study:
- To identify the specific genetic mutation responsible for CHD in the affected family.
- To elucidate the functional consequences of the identified mutation on NKX2.5 protein activity.
Main Methods:
- Direct DNA sequencing was employed to detect mutations in the NKX2.5 gene.
- Functional characterization involved luciferase reporter assays and immunostaining to assess protein localization and activity.
Main Results:
- A novel, de novo 2-bp insertion (c.512insGC) in exon 2 of NKX2.5 was identified and co-segregated with CHD in the family.
- The c.512insGC mutation impaired NKX2.5 nuclear localization and abolished its transactivation activity.
- No NKX2.5 mutations were found in 125 sporadic Chinese CHD patients, suggesting rarity in sporadic cases.
Conclusions:
- The NKX2.5 mutation c.512insGC is linked to ASDs, syncope, and sudden death, expanding the known spectrum of NKX2.5-related disorders.
- This represents the second identified de novo NKX2.5 mutation.
- The study provides the first evidence associating an NKX2.5 mutation with ventricular noncompaction.
Background:
Mutations in transcription factor NKX2.5 cause congenital heart disease (CHD). We identified a CHD family with atrial septal defects (ASDs), atrioventricular block, ventricular noncompaction, syncope and sudden death. Our objective is to identify the disease-causing mutation in the CHD family.
Methods:
Direct DNA sequence analysis was used to identify the CHD mutation. The functional effects of the mutation were characterized by a luciferase reporter assay and immunostaining.
Results:
A novel, de novo 2-bp insertion (c.512insGC) was identified in exon 2 of NKX2.5. Mutation c.512insGC co-segregates with CHD in the family, and is not present in 200 controls. Functional studies indicate that the c.512insGC mutation impedes nuclear localization of NKX2.5 and causes a total loss of transactivation activity of NKX2.5. Furthermore, no NKX2.5 mutation was identified in 125 sporadic Chinese CHD patients.
Conclusions:
(1) NKX2.5 mutation c.512insGC is associated with ASDs, syncope and sudden death. It is the second de novo mutation identified in NKX2.5. (2) NKX2.5 mutations are rare in sporadic CHD patients. (3) This study for the first time identifies association between a NKX2.5 mutation and ventricular noncompaction. Our results significantly expand the phenotypic spectrum of NKX2.5 mutations.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification

